Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: Implications for daptomycin Resistance

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 10, 2010, Pages 4476-4479

  Kilelee, Erin ^a   Pokorny, Antje ^a   Yeaman, Michael R ^b   Bayer, Arnold S ^b  

^a UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; ANTIMICROBIAL CATIONIC PEPTIDE 6W RP 1; DAPTOMYCIN; LYSOPHOSPHATIDYLGLYCEROL; PHOSPHATIDYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFICIAL MEMBRANE; BACTERIAL CELL; CELL PERMEABILIZATION; DRUG PROTEIN BINDING; HOST RESISTANCE; LIPID VESICLE; MEMBRANE BINDING; MICROBIAL ATTENUATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; LIPID BILAYERS; LYSINE; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPIDS;

EID: 77957330217     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00191-10     Document Type: Article

References (20)

1. Almeida, P. F., and A. Pokorny. 2010. Binding and permeabilization of model membranes by amphipathic peptides. Methods Mol. Biol. 618:155-169.
2. Arouri, A., M. Dathe, and A. Blume. 2009. Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochim. Biophys. Acta 1788:650-659.
3. Epand, R. F., G. Wang, B. Berno, and R. M. Epand. 2009. Lipid segregation explains selective toxicity of a series of fragments derived from the human cathelicidin LL-37. Antimicrob. Agents Chemother. 53:3705-3714.
4. Gehman, J. D., F. Luc, K. Hall, T. H. Lee, M. P. Boland, T. L. Pukala, J. H. Bowie, M. I. Aguilar, and F. Separovic. 2008. Effect of antimicrobial peptides from Australian tree frogs on anionic phospholipid membranes. Biochemistry 47:8557-8565.
5. Gregory, S. M., A. Cavenaugh, V. Journigan, A. Pokorny, and P. F. Almeida. 2008. A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. Biophys. J. 94:1667-1680.
6. Hachmann, A. B., E. R. Angert, and J. D. Helmann. 2009. Genetic analysis of factors affecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob. Agents Chemother. 53:1598-1609.
7. Houtsmuller, U. M., and L. van Deenen. 1963. Identification of a bacterial phospholipid as an O-ornithine ester of phosphatidyl glycerol. Biochim. Biophys. Acta 70:211-213.
8. Jones, T., M. R. Yeaman, G. Sakoulas, S.-J. Yang, R. A. Proctor, H.-G. Sahl, J. Schrenzel, Y. Q. Xiong, and A. S. Bayer. 2008. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob. Agents Chemother. 52:269-278.
9. Mishra, N. N., S. J. Yang, A. Sawa, A. Rubio, C. C. Nast, M. R. Yeaman, and A. S. Bayer. 2009. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:2312-2318.
10. Nishi, H., H. Komatsuzawa, T. Fujiwara, N. McCallum, and M. Sugai. 2004. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:4800-4807. (Pubitemid 39577687)
11. O'Leary, W. M., and S. G. Wilkinson. 1988. Gram-positive bacteria, p. 117-201. In C. Ratledge and S. G. Wilkinson (ed.), Microbial lipids, vol. 1. Academic Press, San Diego, CA.
12. Peschel, A., R. W. Jack, M. Otto, L. V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W. F. Nieuwenhuizen, G. Jung, A. Tarkowski, K. P. van Kessel, and J. A. van Strijp. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J. Exp. Med. 193:1067-1076.
13. RajBhandary, U. L., and D. Söll. 2008. Aminoacyl-tRNAs, the bacterial cell envelope, and antibiotics. Proc. Natl. Acad. Sci. U. S. A. 105:5285-5286.
14. Roy, H., and M. Ibba. 2008. RNA-dependent lipid remodeling by bacterial multiple peptide resistance factors. Proc. Natl. Acad. Sci. U. S. A. 105:4667-4672.
15. Short, S. A., and D. C. White. 1971. Metabolism of phosphatidylglycerol, lysyl-phosphatidylglycerol, and cardiolipin of Staphylococcus aureus. J. Bacteriol. 108:219-226.
16. Staubitz, P., H. Neumann, T. Schneider, I. Wiedemann, and A. Peschel. 2004. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 231:67-71.
17. Thedieck, K., T. Hain, W. Mohamed, B. J. Tindall, M. Nimtz, T. Chakraborty, J. Wehland, and L. Jänsch. 2006. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol. Microbiol. 62:1325-1339.
18. Weidenmaier, C., A. Peschel, V. A. Kempf, N. Lucindo, M. R. Yeaman, and A. S. Bayer. 2005. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 73:8033-8038.
19. Xiong, Y. Q., K. Mukhopadhyay, M. R. Yeaman, J. Adler-Moore, and A. S. Bayer. 2005. Functional interrelationships between cell membrane and cell wall in antimicrobial peptide-mediated killing of Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3114-3121.
20. Yeaman, M. R., K. D. Gank, A. S. Bayer, and E. P. Brass. 2002. Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob. Agents Chemother. 46:3883-3891.